Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.

Torosyan, Nare

Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. [electronic resource] - Experimental gerontology 10 2018 - 118-121 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1873-6815

10.1016/j.exger.2018.07.009 doi


Aged
Aged, 80 and over
Alzheimer Disease--drug therapy
Apolipoproteins E--genetics
Brain--physiopathology
Brain Mapping
Cerebrovascular Circulation--drug effects
Cognition
Diet, Ketogenic
Double-Blind Method
Female
Humans
Ketone Bodies--metabolism
Male
Middle Aged
Pilot Projects
Positron-Emission Tomography
Triglycerides--pharmacology